Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North AmericaJennifer K Quint, Yvette M. Weesie, Javier Nuevo et al.|The Journal of Allergy and Clinical Immunology In Practice|2022Cited by 79
Effectiveness and safety of allergen immunotherapy in autoimmune diseases: a real-world retrospective analysisDominika Ochab, Cezary Pałczyński, Piotr Lacwik et al.|Alergologia Polska - Polish Journal of Allergology|2026Cited by 0